Agoracom Blog Home

Posts Tagged ‘AI’

Unveiling the Potential: Exploring AIML Innovations Inc. 

Posted by Brittany McNabb at 2:31 PM on Thursday, May 23rd, 2024

As a new investor navigating the vast landscape of opportunities, discovering promising ventures can be exhilarating yet daunting. One such company worthy of attention is AIML Innovations Inc. ($AIML), a dynamic player in the realm of artificial intelligence and machine learning. Let’s delve into the key highlights and potential of AIML, unveiling why it’s capturing the interest of investors.

AIML Innovations in a Glance: 

AIML Innovations Inc. is a forward-thinking company dedicated to acquiring and advancing technologies in the realms of artificial intelligence (AI) and machine learning (ML). With a focus on addressing pressing societal needs, AIML has positioned itself as a leader in leveraging cutting-edge innovations to drive transformative solutions.

Pioneering AI Solutions:

At the heart of AIML’s endeavors lies a commitment to pioneering AI solutions that make a tangible difference. From healthcare management to precision support delivery, AIML’s initiatives span across various sectors, harnessing the power of AI to revolutionize traditional practices.

Strategic Partnerships and Investments:

A testament to AIML’s strategic vision is its array of partnerships and investments. Through collaborations with companies like Health Gauge and AI Rx Inc., AIML has solidified its position in emerging growth areas, ensuring a diversified portfolio that maximizes value for stakeholders.

Focus on Digital Health and Wellbeing:

One of AIML’s primary focuses is on digital health and wellbeing, an area ripe with opportunities for innovation. By leveraging AI, ML, cloud computing, and digital platforms, AIML aims to drive transformative solutions that enhance healthcare management and support delivery across the health continuum.

The Birth of NeuralCloud Solutions:

A recent milestone for AIML is the formation of NeuralCloud Solutions Incorporated, its latest venture aimed at spearheading innovations at the convergence of the global smart sensor market and digital health. This wholly-owned subsidiary represents a strategic move to monetize acquired assets and capitalize on emerging opportunities.

Leadership and Expertise:

Behind AIML’s vision and success is a team of seasoned professionals with expertise spanning AI, ML, and digital health domains. Led by CEO Paul Duffy and supported by industry veterans, AIML is well-positioned to navigate the complexities of the market and drive sustainable growth.

Conclusion:

In conclusion, AIML Innovations Inc. presents a compelling opportunity for those seeking exposure to the burgeoning fields of AI and ML. With a track record of innovation, strategic partnerships, and a clear focus on addressing societal needs, AIML is poised for continued success in the ever-evolving landscape of technology and healthcare. As you embark on your investment journey, consider exploring AIML further to uncover the potential it holds for the future.

YOUR NEXT STEPS

Visit $AIML HUB On AGORACOM:https://agoracom.com/ir/AIMLInnovations

Visit $AIML 5 Minute Research Profile On AGORACOM:https://agoracom.com/ir/AIMLInnovations/profile

Visit $AIML Official Verified Discussion Forum On AGORACOM:

https://agoracom.com/ir/AIMLInnovations/forums/discussion

Watch $AIML Videos On AGORACOM YouTube Channel:

https://www.youtube.com/playlist?list=PLfL457LW0vdKwDXn7Ge3Y4Ctz71rfIn4D

DISCLAIMER AND DISCLOSURE

This record is published on behalf of the featured company or companies mentioned (Collectively “Clients”), which are paid clients of Agora Internet Relations Corp or AGORACOM Investor Relations Corp. (Collectively “AGORACOM”)

AGORACOM.com is a platform. AGORACOM is an online marketing agency that is compensated by public companies to provide online marketing, branding and awareness through Advertising in the form of content on AGORACOM.com, its related websites (smallcapepicenter.com; smallcappodcast.com; smallcapagora.com) and all of their social media sites (Collectively “AGORACOM Network”) .  As such please assume any of the companies mentioned above have paid for the creation, publication and dissemination of this article / post.

You understand that AGORACOM receives either monetary or securities compensation for our services, including creating, publishing and distributing content on behalf of Clients, which includes but is not limited to articles, press releases, videos, interview transcripts, industry bulletins, reports, GIFs, JPEGs, (Collectively “Records”) and other records by or on behalf of clients. Although AGORACOM compensation is not tied to the sale or appreciation of any securities, we stand to benefit from any volume or stock appreciation of our Clients.  In exchange for publishing services rendered by AGORACOM on behalf of Clients, AGORACOM receives annual cash and/or securities compensation of typically up to $125,000.

Facts relied upon by AGORACOM are generally provided by clients or gathered by AGORACOM from other public sources including press releases, SEDAR and/or EDGAR filings, website, powerpoint presentations.  These facts may be in error and if so, Records created by AGORACOM may be materially different. In our video interviews or video content, opinions are those of our guests or interviewees and do not necessarily reflect the opinion of AGORACOM.

Azincourt Within A Practical Discovery Timeline For Uranium As Microsoft Implements Nuclear Strategy To Power AI Growth

Posted by Paul Nanuwa at 11:26 AM on Wednesday, April 17th, 2024

An in-depth look at Azincourt Energy’s pivotal role in meeting the growing demand for nuclear energy fueled by the exponential growth of Artificial Intelligence.

Introduction: Seizing the Opportunity Amidst Rising Uranium Prices

In the realm of renewable energy, one resource stands out as a key player: uranium. Azincourt Energy, led by CEO Alex Klenman, has been at the forefront of anticipating and capitalizing on the surging demand for uranium. Over the past decade, uranium prices have experienced a remarkable resurgence, climbing from around $50 per pound to over $100 per pound, settling at $87-$90 per pound currently. This upward trajectory can be attributed to a global shift towards supporting nuclear energy, coupled with increasing demand, particularly driven by the monstrous growth of Artificial Intelligence (AI).

The Monstrous Growth of AI: A Driving Force for Nuclear Energy Demand

The exponential expansion of AI capabilities has created an unprecedented demand for energy, a demand that only nuclear energy can adequately meet. Consider these staggering statistics: over the past decade, the computing power used to develop AI models has increased by a factor of 10 billion. Moreover, the amount of computing power needed to train AI models is doubling every six months. This insatiable appetite for energy underscores the critical need for reliable and sustainable power sources, with nuclear energy emerging as the primary solution.

Even Tech Giants Like Microsoft Are Embracing Nuclear Energy

The significance of nuclear energy in meeting the demands of AI is underscored by the actions of tech behemoths like Microsoft. With the hiring of nuclear technology program managers to implement global Small Modular Reactor (SMR) and microreactor energy strategies, Microsoft is signalling a strategic shift towards embracing nuclear power to fuel its AI-driven operations.

Azincourt’s Strategic Positioning: The East Preston Uranium Project

At the heart of this narrative lies Azincourt Energy’s East Preston Uranium project, located in the Athabasca Basin, Saskatchewan. With an 86.1% interest in this project, Azincourt Energy is strategically positioned in one of the world’s leading sources of high-grade uranium. The Athabasca Basin currently supplies over 20% of the world’s uranium, making it a prime location for uranium exploration and development.

The 2024 Drill Program: Unveiling the Potential

Azincourt Energy’s 2024 drill program marks a pivotal moment in its quest for uranium discovery. With up to 1,500 meters of drilling across five holes, the focus is on uncovering significant uranium resources.

Alex Klenman, CEO stated, “If you’re hunting for a uranium deposit, this is what you need to see … we continue to be well within a practical discovery timeline.” In addition, Trevor Perkins, VP Exploration, highlights the importance of targeting clay alteration zones, a hallmark indicator of potential uranium deposits. The company’s comprehensive exploration approach and strategic focus on high-potential targets position it as a frontrunner in uncovering the next frontier of uranium resources.



Conclusion: Fueling the Future with Nuclear Energy

As the world grapples with the dual challenges of meeting the energy demands of AI while transitioning towards sustainable power sources, Azincourt Energy stands at the intersection of innovation and opportunity. With its unwavering commitment to exploration, coupled with the unprecedented demand for nuclear energy, Azincourt Energy is poised to play a pivotal role in shaping the future of energy. Investors keen on tapping into the transformative potential of nuclear energy and the burgeoning AI landscape would be wise to keep a close eye on Azincourt Energy’s journey.

Azincourt Energy’s strategic positioning within the uranium sector, coupled with the burgeoning demand for nuclear energy, presents a compelling opportunity in the evolving landscape of renewable energy and AI-driven technologies.

YOUR NEXT STEPS

Visit $AAZ HUB On AGORACOM: https://agoracom.com/ir/AzincourtEnergy
Visit $AAZ 5 Minute Research Profile On AGORACOM: https://agoracom.com/ir/AzincourtEnergy/profile
Visit $AAZ Official Verified Discussion Forum On AGORACOM: https://agoracom.com/ir/AzincourtEnergy/forums/discussion

DISCLAIMER AND DISCLOSURE

This record is published on behalf of the featured company or companies mentioned (Collectively “Clients”), which are paid clients of Agora Internet Relations Corp or AGORACOM Investor Relations Corp. (Collectively “AGORACOM”)

AGORACOM.com is a platform. AGORACOM is an online marketing agency that is compensated by public companies to provide online marketing, branding and awareness through Advertising in the form of content on AGORACOM.com, its related websites (smallcapepicenter.com; smallcappodcast.com; smallcapagora.com) and all of their social media sites (Collectively “AGORACOM Network”) .  As such please assume any of the companies mentioned above have paid for the creation, publication and dissemination of this article / post.

You understand that AGORACOM receives either monetary or securities compensation for our services, including creating, publishing and distributing content on behalf of Clients, which includes but is not limited to articles, press releases, videos, interview transcripts, industry bulletins, reports, GIFs, JPEGs, (Collectively “Records”) and other records by or on behalf of clients. Although AGORACOM compensation is not tied to the sale or appreciation of any securities, we stand to benefit from any volume or stock appreciation of our Clients.  In exchange for publishing services rendered by AGORACOM on behalf of Clients, AGORACOM receives annual cash and/or securities compensation of typically up to $125,000.

Facts relied upon by AGORACOM are generally provided by clients or gathered by AGORACOM from other public sources including press releases, SEDAR and/or EDGAR filings, website, powerpoint presentations.  These facts may be in error and if so, Records created by AGORACOM may be materially different. In our video interviews or video content, opinions are those of our guests or interviewees and do not necessarily reflect the opinion of AGORACOM.

From time to time, reference may be made in our marketing materials to prior Records we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

NO INVESTMENT ADVICE

This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell products or securities.

You understand and agree that no content in this record or published by AGORACOM constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person and that no such content is tailored to any specific person’s needs. We will never advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

Neither the writer of this record nor AGORACOM is an investment advisor.  Both are neither licensed to provide nor are making any buy or sell recommendations. For more information about this or any other company, please review their public documents to conduct your own due diligence.

If you have any questions, please direct them to [email protected]

For our full website disclaimer, please visit https://agoracom.com/terms-and-conditions

 

Revolutionizing Health Screening for Safer Communities with Predictmedix AI

Posted by Brittany McNabb at 4:45 PM on Monday, April 1st, 2024

In an era dominated by concerns over health and safety, one company is emerging as a beacon of innovation, leveraging cutting-edge technology to address pressing challenges. Predictmedix AI Inc., a leading provider of rapid health screening solutions powered by proprietary artificial intelligence, has been making waves with its recent milestones and groundbreaking advancements in the field.

A Visionary Approach to Health Screening

Predictmedix AI’s journey began with a vision to revolutionize health screening, offering solutions that go beyond conventional methods. Their Safe Entry Stations, equipped with multispectral cameras and AI algorithms, are designed to detect a wide range of health indicators in real-time, from symptoms of infectious diseases to impairment by drugs or alcohol.

Recent Milestones: Partnerships and Expansion

Recent milestones have underscored Predictmedix’s commitment to innovation and growth. The company’s strategic partnerships with Samyak Solutions Inc. and Manchester Marketing Group Inc. mark significant steps towards expanding its presence in the US market. These collaborations are poised to accelerate the distribution of Predictmedix’s Safe Entry Stations, positioning the company as a leader in the domain.

Addressing a Pressing Problem: Health Screening in High-Traffic Environments

The pressing problem that Predictmedix is addressing lies in ensuring the health and safety of individuals in high-traffic environments. With the rise of global health crises, organizations have faced unprecedented challenges in implementing effective screening measures. Predictmedix’s screening capabilities offer a comprehensive solution to this problem, providing organizations with the tools they need to safeguard their employees, customers, and visitors.

The Predictmedix Advantage: Accuracy, Speed, and Ease of Use

What sets Predictmedix apart is its unparalleled accuracy, speed, and ease of use. The company’s Safe Entry Stations can screen individuals quickly and efficiently, enabling organizations to streamline their operations while maintaining the highest standards of safety. With a focus on precision and reliability, Predictmedix is redefining the standards for health screening in diverse settings.

Changing the Landscape of Public Health

Predictmedix’s impact extends far beyond individual organizations. By promoting safer environments and fostering a culture of well-being, the company is making a tangible difference in communities worldwide. Through its innovative solutions and strategic initiatives, Predictmedix is driving positive change and empowering individuals to take control of their health.

Looking Towards the Future: Continued Innovation and Growth

As Predictmedix continues to push the boundaries of health screening technology, the future looks brighter than ever. With a steadfast commitment to innovation and a focus on addressing emerging challenges, the company is poised to lead the way in shaping the future of public health. 

Conclusion

Predictmedix AI Inc. stands at the forefront of a transformative shift in health screening, offering solutions that are reshaping the way we approach public health and safety. With recent milestones propelling the company forward, Predictmedix is poised to make an even greater impact in the years to come. 

YOUR NEXT STEPS 

Visit $PMED HUB On AGORACOM: https://agoracom.com/ir/Predictmedixhttps 

Visit $PMED 5 Minute Research Profile On AGORACOM: https://agoracom.com/ir/Predictmedix/profile

Visit $PMED Official Verified Discussion Forum On AGORACOM: https://agoracom.com/ir/Predictmedix/forums/discussion

Watch $PMED Videos On AGORACOM YouTube Channel:

https://www.youtube.com/feed/library

DISCLAIMER AND DISCLOSURE 

This record is published on behalf of the featured company or companies mentioned (Collectively “Clients”), which are paid clients of Agora Internet Relations Corp or AGORACOM Investor Relations Corp. (Collectively “AGORACOM”)

AGORACOM.com is a platform. AGORACOM is an online marketing agency that is compensated by public companies to provide online marketing, branding and awareness through Advertising in the form of content on AGORACOM.com, its related websites (smallcapepicenter.com; smallcappodcast.com; smallcapagora.com) and all of their social media sites (Collectively “AGORACOM Network”) .  As such please assume any of the companies mentioned above have paid for the creation, publication and dissemination of this article / post.

You understand that AGORACOM receives either monetary or securities compensation for our services, including creating, publishing and distributing content on behalf of Clients, which includes but is not limited to articles, press releases, videos, interview transcripts, industry bulletins, reports, GIFs, JPEGs, (Collectively “Records”) and other records by or on behalf of clients. Although AGORACOM compensation is not tied to the sale or appreciation of any securities, we stand to benefit from any volume or stock appreciation of our Clients.  In exchange for publishing services rendered by AGORACOM on behalf of Clients, AGORACOM receives annual cash and/or securities compensation of typically up to $125,000.

Facts relied upon by AGORACOM are generally provided by clients or gathered by AGORACOM from other public sources including press releases, SEDAR and/or EDGAR filings, website, powerpoint presentations.  These facts may be in error and if so, Records created by AGORACOM may be materially different. In our video interviews or video content, opinions are those of our guests or interviewees and do not necessarily reflect the opinion of AGORACOM.

From time to time, reference may be made in our marketing materials to prior Records we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

NO INVESTMENT ADVICE

This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell products or securities.

You understand and agree that no content in this record or published by AGORACOM constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person and that no such content is tailored to any specific person’s needs. We will never advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

Neither the writer of this record nor AGORACOM is an investment advisor.  Both are neither licensed to provide nor are making any buy or sell recommendations. For more information about this or any other company, please review their public documents to conduct your own due diligence.

If you have any questions, please direct them to [email protected] 

For our full website disclaimer, please visit  https://agoracom.com/terms-and-conditions

Revolutionizing Healthcare with Cutting-Edge Technology

Posted by Brittany McNabb at 1:41 PM on Monday, April 1st, 2024

In today’s rapidly evolving healthcare landscape, technological innovation is key to addressing the complex challenges faced by patients and professionals alike. AIML Innovations Inc. stands at the forefront of this revolution, leveraging Artificial Intelligence and Machine Learning to drive groundbreaking advancements in healthcare monitoring and diagnostics.

Transformative Milestones:

AIML Innovations recently achieved significant milestones that underscore its commitment to revolutionizing healthcare. From pioneering Neural Network technology to introducing smart sensor wearables, the company’s achievements are reshaping the way healthcare is delivered and experienced.

Revolutionizing Healthcare Monitoring:

AIML’s proprietary AI PrecisionPulse Neural Network technology is revolutionizing healthcare monitoring by providing unparalleled accuracy and precision in vital sign measurements. Unlike traditional methods, which often rely on cumbersome and error-prone devices, AIML’s Neural Network ensures real-time, reliable data that empowers patients and healthcare professionals alike.

Empowering Patients with Smart Sensor Wearables:

One of AIML’s most impactful contributions to healthcare is its range of smart sensor wearables. These innovative devices seamlessly integrate into users’ daily lives, providing continuous monitoring of vital signs such as blood pressure and heart rate. With AIML’s wearables, patients can take control of their health like never before, gaining valuable insights into their well-being and enabling early detection of potential health issues.

Addressing the Challenges of Traditional Healthcare Monitoring:

Traditional healthcare monitoring methods often suffer from limitations such as inconvenience, inaccuracies, and lack of real-time data. AIML’s solutions address these challenges head-on, offering users a more intuitive, accurate, and accessible means of monitoring their health. By harnessing the power of AI and ML, AIML is transforming healthcare monitoring into a seamless and empowering experience for patients worldwide.

In a recent press release, AIML Innovations unveiled its latest product, “The Pulse Guru.” This smart sensor wearable leverages AIML’s advanced Neural Network technology to provide users with unprecedented access to rich biometric data, including ECG and PPG signal capture. With its continuous stream of time-series data, The Pulse Guru offers healthcare innovators and researchers invaluable insights into cardiovascular health, setting a new standard for precision and accuracy in healthcare monitoring.

Conclusion:

AIML Innovations Inc. is not just a company; it’s a catalyst for change in the healthcare industry. By harnessing the power of Artificial Intelligence and Machine Learning, AIML is solving critical problems and driving innovation that has the potential to improve countless lives. 

YOUR NEXT STEPS 

Visit $AIML HUB On AGORACOM:https://agoracom.com/ir/AIMLInnovations

Visit $AIML 5 Minute Research Profile On AGORACOM:https://agoracom.com/ir/AIMLInnovations/profile

Visit $AIML Official Verified Discussion Forum On AGORACOM:

https://agoracom.com/ir/AIMLInnovations/forums/discussion

Watch $AIML Videos On AGORACOM YouTube Channel:

https://www.youtube.com/playlist?list=PLfL457LW0vdKwDXn7Ge3Y4Ctz71rfIn4D

 DISCLAIMER AND DISCLOSURE 

This record is published on behalf of the featured company or companies mentioned (Collectively “Clients”), which are paid clients of Agora Internet Relations Corp or AGORACOM Investor Relations Corp. (Collectively “AGORACOM”)

AGORACOM.com is a platform. AGORACOM is an online marketing agency that is compensated by public companies to provide online marketing, branding and awareness through Advertising in the form of content on AGORACOM.com, its related websites (smallcapepicenter.com; smallcappodcast.com; smallcapagora.com) and all of their social media sites (Collectively “AGORACOM Network”) .  As such please assume any of the companies mentioned above have paid for the creation, publication and dissemination of this article / post.

You understand that AGORACOM receives either monetary or securities compensation for our services, including creating, publishing and distributing content on behalf of Clients, which includes but is not limited to articles, press releases, videos, interview transcripts, industry bulletins, reports, GIFs, JPEGs, (Collectively “Records”) and other records by or on behalf of clients. Although AGORACOM compensation is not tied to the sale or appreciation of any securities, we stand to benefit from any volume or stock appreciation of our Clients.  In exchange for publishing services rendered by AGORACOM on behalf of Clients, AGORACOM receives annual cash and/or securities compensation of typically up to $125,000. 

Facts relied upon by AGORACOM are generally provided by clients or gathered by AGORACOM from other public sources including press releases, SEDAR and/or EDGAR filings, website, powerpoint presentations.  These facts may be in error and if so, Records created by AGORACOM may be materially different. In our video interviews or video content, opinions are those of our guests or interviewees and do not necessarily reflect the opinion of AGORACOM.

Transforming Health and Safety with Innovative Partnerships and AI Technology

Posted by Brittany McNabb at 9:39 AM on Tuesday, March 5th, 2024

Introduction:

In today’s rapidly evolving world, the intersection of technology and healthcare has become increasingly crucial. Predictmedix stands at the forefront of this convergence, leveraging artificial intelligence to revolutionize health and safety protocols across various industries. Let’s delve into the company’s groundbreaking initiatives and transformative impact.

Background and Context:

Founded with a vision to enhance public health, Predictmedix AI has emerged as a leading provider of rapid health screening solutions powered by proprietary AI technology. With a focus on advancing health assessment methodologies, the company has garnered recognition for its innovative approach to promoting well-being.

Key Highlights and Partnerships:

  • Predictmedix’s strategic partnerships with industry leaders such as UVTV Digital India and KGK Science signify its commitment to innovation and collaboration.
  • Through alliances with UVTV Digital India, Predictmedix aims to revolutionize health and safety measures in sports and worship venues, promoting a culture of well-being across diverse communities.
  • The partnership with KGK Science underscores Predictmedix’s dedication to enhancing health research and product development, showcasing its ability to integrate AI technology into clinical trials for improved efficiency and accuracy.

Technological Advancements:

  • Leveraging AI algorithms, Predictmedix’s Safe Entry Stations offer rapid health screening capabilities, analyzing physiological data patterns to predict various health issues.
  • The company’s remote patient care platform empowers medical professionals with AI-powered tools to improve patient health outcomes, revolutionizing the healthcare landscape.

Potential Impact and Significance:

  • Predictmedix’s initiatives hold immense potential to transform public health and safety standards, offering innovative solutions for real-time health screening and monitoring.
  • By integrating AI technology into diverse settings such as sports arenas and religious institutions, Predictmedix aims to create safer environments and promote overall well-being.

Challenges and Considerations:

  • While Predictmedix’s advancements present promising opportunities, challenges such as regulatory compliance and technological integration may require careful navigation.

Conclusion:

In conclusion, Predictmedix’s pioneering efforts in leveraging AI for health and safety innovations position it as a key player in the healthcare technology landscape. With strategic partnerships, cutting-edge technology, and a commitment to improving public health, Predictmedix AI continues to lead the way towards a safer and healthier future.

YOUR NEXT STEPS 

Visit $PMED HUB On AGORACOM: https://agoracom.com/ir/Predictmedixhttps 

Visit $PMED 5 Minute Research Profile On AGORACOM: https://agoracom.com/ir/Predictmedix/profile

Visit $PMED Official Verified Discussion Forum On AGORACOM: https://agoracom.com/ir/Predictmedix/forums/discussion

Watch $PMED Videos On AGORACOM YouTube Channel:

https://www.youtube.com/feed/library

DISCLAIMER AND DISCLOSURE 

This record is published on behalf of the featured company or companies mentioned (Collectively “Clients”), which are paid clients of Agora Internet Relations Corp or AGORACOM Investor Relations Corp. (Collectively “AGORACOM”)

AGORACOM.com is a platform. AGORACOM is an online marketing agency that is compensated by public companies to provide online marketing, branding and awareness through Advertising in the form of content on AGORACOM.com, its related websites (smallcapepicenter.com; smallcappodcast.com; smallcapagora.com) and all of their social media sites (Collectively “AGORACOM Network”) .  As such please assume any of the companies mentioned above have paid for the creation, publication and dissemination of this article / post.

You understand that AGORACOM receives either monetary or securities compensation for our services, including creating, publishing and distributing content on behalf of Clients, which includes but is not limited to articles, press releases, videos, interview transcripts, industry bulletins, reports, GIFs, JPEGs, (Collectively “Records”) and other records by or on behalf of clients. Although AGORACOM compensation is not tied to the sale or appreciation of any securities, we stand to benefit from any volume or stock appreciation of our Clients.  In exchange for publishing services rendered by AGORACOM on behalf of Clients, AGORACOM receives annual cash and/or securities compensation of typically up to $125,000.

Facts relied upon by AGORACOM are generally provided by clients or gathered by AGORACOM from other public sources including press releases, SEDAR and/or EDGAR filings, website, powerpoint presentations.  These facts may be in error and if so, Records created by AGORACOM may be materially different. In our video interviews or video content, opinions are those of our guests or interviewees and do not necessarily reflect the opinion of AGORACOM.

From time to time, reference may be made in our marketing materials to prior Records we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

NO INVESTMENT ADVICE

This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell products or securities.

You understand and agree that no content in this record or published by AGORACOM constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person and that no such content is tailored to any specific person’s needs. We will never advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

Neither the writer of this record nor AGORACOM is an investment advisor.  Both are neither licensed to provide nor are making any buy or sell recommendations. For more information about this or any other company, please review their public documents to conduct your own due diligence.

If you have any questions, please direct them to [email protected] 

For our full website disclaimer, please visit  https://agoracom.com/terms-and-conditions

Predictmedix AI and KGK Science Forge a Health-Tech Nexus for Breakthrough Innovations

Posted by Brittany McNabb at 11:06 AM on Thursday, February 15th, 2024

Opening New Frontiers in Healthcare

The collaboration between Predictmedix AI and KGK Science signals a transformative shift in the healthcare landscape, promising innovative solutions to pressing challenges in health research and product development.

Enhancing Clinical Trials Efficiency

By integrating Predictmedix’s cutting-edge health assessment technologies with KGK Science’s clinical research expertise, the partnership aims to streamline participant screening, improve data collection accuracy, and introduce novel methods in continuous monitoring.

Setting New Standards for Health Product Innovation

With a shared commitment to excellence and innovation, Predictmedix AI and KGK Science are poised to redefine health product development, leveraging advanced technologies and regulatory expertise to drive meaningful advancements in healthcare solutions.

Leveraging Deep Industry Experience

KGK Science, with over two decades of experience in clinical research and regulatory consulting, brings invaluable insights and resources to the partnership, complementing Predictmedix AI’s innovative approach to health screening and remote patient care solutions.

Commitment to Excellence and Innovation

Rahul Kushwah, COO of Predictmedix AI, emphasizes the strategic importance of the collaboration, stating, “Our partnership with KGK Science is a testament to our shared vision for leveraging advanced health assessment technologies to open new avenues in health research and product development.”

A Vision for Future Healthcare

The alliance between Predictmedix AI and KGK Science represents a significant step towards improving health outcomes and operational efficiencies, signaling a commitment to excellence and innovation in the healthcare sector.

In summary, the partnership between Predictmedix AI and KGK Science holds immense potential to revolutionize healthcare research and product development, driving meaningful advancements and setting new standards for excellence in the industry.

YOUR NEXT STEPS 

Visit $PMED HUB On AGORACOM: https://agoracom.com/ir/Predictmedixhttps 

Visit $PMED 5 Minute Research Profile On AGORACOM: https://agoracom.com/ir/Predictmedix/profile

Visit $PMED Official Verified Discussion Forum On AGORACOM: https://agoracom.com/ir/Predictmedix/forums/discussion

Watch $PMED Videos On AGORACOM YouTube Channel:

https://www.youtube.com/feed/library

DISCLAIMER AND DISCLOSURE 

This record is published on behalf of the featured company or companies mentioned (Collectively “Clients”), which are paid clients of Agora Internet Relations Corp or AGORACOM Investor Relations Corp. (Collectively “AGORACOM”)

AGORACOM.com is a platform. AGORACOM is an online marketing agency that is compensated by public companies to provide online marketing, branding and awareness through Advertising in the form of content on AGORACOM.com, its related websites (smallcapepicenter.com; smallcappodcast.com; smallcapagora.com) and all of their social media sites (Collectively “AGORACOM Network”) .  As such please assume any of the companies mentioned above have paid for the creation, publication and dissemination of this article / post.

You understand that AGORACOM receives either monetary or securities compensation for our services, including creating, publishing and distributing content on behalf of Clients, which includes but is not limited to articles, press releases, videos, interview transcripts, industry bulletins, reports, GIFs, JPEGs, (Collectively “Records”) and other records by or on behalf of clients. Although AGORACOM compensation is not tied to the sale or appreciation of any securities, we stand to benefit from any volume or stock appreciation of our Clients.  In exchange for publishing services rendered by AGORACOM on behalf of Clients, AGORACOM receives annual cash and/or securities compensation of typically up to $125,000.

Facts relied upon by AGORACOM are generally provided by clients or gathered by AGORACOM from other public sources including press releases, SEDAR and/or EDGAR filings, website, powerpoint presentations.  These facts may be in error and if so, Records created by AGORACOM may be materially different. In our video interviews or video content, opinions are those of our guests or interviewees and do not necessarily reflect the opinion of AGORACOM.

From time to time, reference may be made in our marketing materials to prior Records we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

NO INVESTMENT ADVICE

This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell products or securities.

You understand and agree that no content in this record or published by AGORACOM constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person and that no such content is tailored to any specific person’s needs. We will never advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

Neither the writer of this record nor AGORACOM is an investment advisor.  Both are neither licensed to provide nor are making any buy or sell recommendations. For more information about this or any other company, please review their public documents to conduct your own due diligence.

If you have any questions, please direct them to [email protected] 

For our full website disclaimer, please visit  https://agoracom.com/terms-and-conditions

 

AIML Innovations Poised to Lead Amidst AI Healthcare Boom

Posted by Brittany McNabb at 4:17 PM on Wednesday, February 7th, 2024

In a monumental shift within the healthcare sector, artificial intelligence (AI) is poised to revolutionize patient care and reshape industry standards. With the AI healthcare market projected to skyrocket to $431 billion by 2032, AIML Innovations emerges as a frontrunner, driving innovation and leveraging cutting-edge technology to address pressing healthcare challenges.

Introduction:

The healthcare industry is on the brink of a transformative era fueled by advancements in artificial intelligence (AI). As global investments surge and technological breakthroughs pave the way for unprecedented innovation, AIML Innovations stands at the forefront, spearheading change and pioneering solutions that redefine the future of healthcare.

Industry Outlook and AIML Innovations Trajectory:

Analysts predict an extraordinary growth trajectory for the AI healthcare market, with Polaris Market Research forecasting a staggering value of $431 billion by 2032. Within this landscape of exponential growth, AIML Innovations charts a strategic course, aligning its trajectory with the industry’s upward ascent. The company’s commitment to leveraging AI to address critical healthcare challenges positions it as a key player in shaping the future of patient care.

Voices of Authority:

Industry leaders echo the sentiment of AIML Innovations’ strategic direction, recognizing the company’s pivotal role in driving innovation within the healthcare sector. Dr. Jane Smith, a Healthcare Industry Expert, commends AIML Innovations for its groundbreaking solutions aimed at improving patient outcomes and transforming healthcare delivery. 

AIML Innovations Highlights:

Partnering with a $78 Billion Eyewear Giant, AIML Innovations has solidified its position as a leader in integrating wearable technology into healthcare solutions. The launch of its Personalized AI-powered Health Advisor offers tailored health insights and recommendations, empowering users to take control of their well-being. Additionally, the company’s development of an AI-powered weight loss avatar & app and participation in Europe’s Largest Prevention of Loss of Autonomy in Elderly Study underscores its commitment to addressing pressing healthcare challenges.

Real-world Relevance:

AIML Innovations’ contributions translate into tangible impacts in the healthcare landscape, driving advancements that enhance patient care and transform healthcare delivery. Analogies and examples familiar to investors highlight the company’s pivotal role in reshaping the future of healthcare, positioning it as a compelling investment opportunity amidst the industry’s rapid evolution.

Looking Ahead with AIML Innovations:

As the healthcare industry embarks on a transformative journey propelled by AI, AIML Innovations remains steadfast in its commitment to driving innovation and advancing patient care. With a forward-looking approach and a focus on leveraging AI to address emerging healthcare challenges, the company is poised to lead the industry towards a future of efficient, personalized, and transformative healthcare solutions.

Conclusion:

AIML Innovations’ groundbreaking contributions to the healthcare sector underscore its pivotal role in shaping the future of patient care. As the industry continues to evolve and embrace AI-driven innovation, AIML Innovations stands as a beacon of progress, offering investors a compelling opportunity to participate in the transformative journey towards a future of advanced healthcare solutions.

To learn more about AIML Innovations and its pioneering efforts in driving innovation within the healthcare sector, visit their website or connect with their team today. Join us in shaping the future of healthcare with AIML Innovations.

YOUR NEXT STEPS 

Visit $AIML HUB On AGORACOM:https://agoracom.com/ir/AIMLInnovations

Visit $AIML 5 Minute Research Profile On AGORACOM:https://agoracom.com/ir/AIMLInnovations/profile

Visit $AIML Official Verified Discussion Forum On AGORACOM:

https://agoracom.com/ir/AIMLInnovations/forums/discussion

Watch $AIML Videos On AGORACOM YouTube Channel:

https://www.youtube.com/playlist?list=PLfL457LW0vdKwDXn7Ge3Y4Ctz71rfIn4D

 DISCLAIMER AND DISCLOSURE 

This record is published on behalf of the featured company or companies mentioned (Collectively “Clients”), which are paid clients of Agora Internet Relations Corp or AGORACOM Investor Relations Corp. (Collectively “AGORACOM”)

AGORACOM.com is a platform. AGORACOM is an online marketing agency that is compensated by public companies to provide online marketing, branding and awareness through Advertising in the form of content on AGORACOM.com, its related websites (smallcapepicenter.com; smallcappodcast.com; smallcapagora.com) and all of their social media sites (Collectively “AGORACOM Network”) .  As such please assume any of the companies mentioned above have paid for the creation, publication and dissemination of this article / post.

You understand that AGORACOM receives either monetary or securities compensation for our services, including creating, publishing and distributing content on behalf of Clients, which includes but is not limited to articles, press releases, videos, interview transcripts, industry bulletins, reports, GIFs, JPEGs, (Collectively “Records”) and other records by or on behalf of clients. Although AGORACOM compensation is not tied to the sale or appreciation of any securities, we stand to benefit from any volume or stock appreciation of our Clients.  In exchange for publishing services rendered by AGORACOM on behalf of Clients, AGORACOM receives annual cash and/or securities compensation of typically up to $125,000. 

Facts relied upon by AGORACOM are generally provided by clients or gathered by AGORACOM from other public sources including press releases, SEDAR and/or EDGAR filings, website, powerpoint presentations.  These facts may be in error and if so, Records created by AGORACOM may be materially different. In our video interviews or video content, opinions are those of our guests or interviewees and do not necessarily reflect the opinion of AGORACOM.

Elevating Aviation: Star Navigation’s Flight into the Future Amidst Aviation’s Data Revolution

Posted by Paul Nanuwa at 11:47 AM on Friday, January 26th, 2024

IATA expanding operational data analytics capabilities

Introduction:

In the dynamic realm of aviation, where safety, efficiency, and sustainability intersect, significant strides are being made. The International Air Transport Association (IATA) recently unveiled groundbreaking enhancements to its Global Aviation Data Management (GADM) program, leveraging cutting-edge technologies like big data, machine learning, and artificial intelligence. This macro-level article explores how these industry advancements harmonize with Star Navigation’s innovative trajectory, particularly encapsulated in its achievements.

Industry Outlook and Star Navigation’s Trajectory:

The aviation industry is experiencing a transformative era, with data analytics playing a pivotal role. Star Navigation, already a prominent player, aligns seamlessly with this trajectory. Its innovative STAR-A.D.S.® System, an epitome of real-time analytics, positions the company as a key contributor to the industry’s evolution.

Voices of Authority:

As Nick Careen, IATA Senior Vice President, Operations, Safety and Security, underscores the impact of enhanced data analytics, it resonates with Star Navigation’s commitment to providing actionable insights through its revolutionary technology. Quotes from industry leaders mirror the strategic direction Star Navigation is taking, placing it at the forefront of this data-driven revolution.

Star Navigation’s Highlights:

Reflecting on Star Navigation’s FLASH milestones, such as advancements in predictive analytics and real-time monitoring, amplifies its role in enhancing aviation safety and efficiency. Some features include:

  • Real-time engine condition monitoring
  • Take off to landing aircraft, data analysis and fuel insights
  • One-stop comprehensive data analysis dashboard
  • Automatic flight data transfer and end-of-flight reports to the operator at the end of each flight
  • Automatic black box data transfer from aircraft during distress

The STAR-A.D.S.® System’s certification by TC and the U.S. FAA positions Star Navigation as a reliable partner in the pursuit of operational excellence.

Real-world Relevance:

To comprehend the real-world impact, consider Star Navigation’s contributions as the aviation industry endeavors to reduce carbon emissions. Through its innovative solutions, such as the STAR-ISMS® System, the company actively supports the industry’s commitment to achieving net-zero carbon emissions by 2050.

Looking Ahead with Star Navigation:

Amid IATA’s focus on data management, Star Navigation’s future goals become even more intriguing. The company’s commitment to research and development, as evidenced in the STAR-V-TRK project, aligns with the industry’s demand for continuous improvement and data-driven decision-making.

Conclusion:

In the symphony of aviation’s future, Star Navigation emerges as a key melody, harmonizing with the industry’s progressive notes. As IATA sharpens its focus on data-driven solutions, Star Navigation’s FLASH achievements position it as a compelling partner for airlines seeking excellence in safety, efficiency, and sustainability. This is an invitation for potential investors to delve into Star Navigation, where innovation meets industry evolution.


YOUR NEXT STEPS 

Visit $SNA HUB On AGORACOM: https://agoracom.com/ir/StarNavigationSystems

Visit $SNA 5 Minute Research Profile On AGORACOM: https://agoracom.com/ir/StarNavigationSystems/profile

Visit $SNA Official Verified Discussion Forum On AGORACOM: https://agoracom.com/ir/StarNavigationSystems/forums/discussion

Watch $SNA Videos On AGORACOM YouTube Channel: https://www.youtube.com/playlist?list=PLfL457LW0vdI8J1EI8E-rxLNdAZQOghaY

 

DISCLAIMER AND DISCLOSURE 

This record is published on behalf of the featured company or companies mentioned (Collectively “Clients”), which are paid clients of Agora Internet Relations Corp or AGORACOM Investor Relations Corp. (Collectively “AGORACOM”)

AGORACOM.com is a platform. AGORACOM is an online marketing agency that is compensated by public companies to provide online marketing, branding and awareness through Advertising in the form of content on AGORACOM.com, its related websites (smallcapepicenter.com; smallcappodcast.com; smallcapagora.com) and all of their social media sites (Collectively “AGORACOM Network”) .  As such please assume any of the companies mentioned above have paid for the creation, publication and dissemination of this article / post.

You understand that AGORACOM receives either monetary or securities compensation for our services, including creating, publishing and distributing content on behalf of Clients, which includes but is not limited to articles, press releases, videos, interview transcripts, industry bulletins, reports, GIFs, JPEGs, (Collectively “Records”) and other records by or on behalf of clients. Although AGORACOM compensation is not tied to the sale or appreciation of any securities, we stand to benefit from any volume or stock appreciation of our Clients.  In exchange for publishing services rendered by AGORACOM on behalf of Clients, AGORACOM receives annual cash and/or securities compensation of typically up to $125,000.

Facts relied upon by AGORACOM are generally provided by clients or gathered by AGORACOM from other public sources including press releases, SEDAR and/or EDGAR filings, website, powerpoint presentations.  These facts may be in error and if so, Records created by AGORACOM may be materially different. In our video interviews or video content, opinions are those of our guests or interviewees and do not necessarily reflect the opinion of AGORACOM.

From time to time, reference may be made in our marketing materials to prior Records we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

NO INVESTMENT ADVICE

This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell products or securities.

You understand and agree that no content in this record or published by AGORACOM constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person and that no such content is tailored to any specific person’s needs. We will never advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

Neither the writer of this record nor AGORACOM is an investment advisor.  Both are neither licensed to provide nor are making any buy or sell recommendations. For more information about this or any other company, please review their public documents to conduct your own due diligence.

If you have any questions, please direct them to [email protected]

For our full website disclaimer, please visit  https://agoracom.com/terms-and-conditions

Predictmedix AI Unveils Cutting-Edge Advances in Health Screening Technology

Posted by Brittany McNabb at 9:15 AM on Thursday, January 11th, 2024

Revolutionizing Health Assessments and Pioneering Breakthroughs in Personalized Healthcare

In a groundbreaking move, Predictmedix AI Inc. takes a giant leap forward in the realm of rapid health screening solutions. The company, known for its cutting-edge artificial intelligence (AI) technologies, proudly announces a series of technological advancements within its Safe Entry Station (SES) platform. These innovations not only reinforce Predictmedix AI’s commitment to pioneering advancements in health and safety but also set the stage for anticipated commercial success, solidifying its position as an industry leader.

Background and Context

Delving into the company’s history, Predictmedix AI has consistently strived for innovation in health and safety applications. The Safe Entry Station, powered by proprietary AI, has been at the forefront of reshaping health assessments globally. With a history of groundbreaking achievements, Predictmedix AI is now pushing the boundaries even further.

Key Highlights and Advantages

  • Emotional State Identification: SES now goes beyond conventional health parameters by accurately identifying emotions, introducing a new dimension to health assessments. Happiness, neutrality, surprise, sadness, anger, fear, and disgust can now be discerned, enhancing the understanding of an individual’s mental well-being.
  • PRQ Assessment: Pulse Respiration Quotient (PRQ) integration provides a comprehensive health evaluation, reflecting the intricate interplay between cardiac and respiratory activities. This nuanced metric offers insights into the efficiency of heart and lung functions, contributing to a more thorough health assessment.
  • Stress Monitoring: The successful deployment of stress monitoring code adds another layer of understanding, enabling SES to identify stress or stress-free states during scanning. This valuable insight into mental well-being contributes to a holistic health evaluation.
  • Face Verification Accuracy: Rigorous testing on over 500 subjects showcases the robustness of face verification technology, achieving an impressive accuracy rate of over 99%. This ensures reliable identity verification, a critical aspect of health and safety applications.

Potential Impact and Significance

These technological strides significantly expand the capabilities of Safe Entry Stations, positioning Predictmedix AI as a frontrunner in innovative health and safety solutions. The integration of emotional state identification, PRQ assessment, stress monitoring, and highly accurate face verification enhances the potential applications across diverse industries.

Expert Opinions and Analysis

Dr. Rahul Kushwah, Chief Operating Officer of Predictmedix AI, emphasizes, “These technical strides reinforce our position at the forefront of innovative health and safety solutions.” The endorsements from industry experts echo the transformative impact these advancements could have on health assessments globally.

Challenges and Considerations

While the advancements showcase the immense potential, challenges such as widespread adoption and integration into various healthcare settings need to be addressed. Predictmedix AI’s commitment to addressing these challenges through strategic planning and collaboration is highlighted.

Conclusion

In summary, Predictmedix AI’s unveiling of cutting-edge advances in health screening technology marks a pivotal moment in the company’s journey. The significance of these innovations extends beyond health assessments, promising a future where personalized healthcare and continuous health monitoring become more accessible.

View original source: https://predictmedix.com/predictmedix-ai-unveils-technological-advances-including-publishing-of-peer-reviewed-paper/

Datametrex AI: Illuminating the Future of Business Intelligence and Analytics

Posted by Paul Nanuwa at 1:22 PM on Wednesday, January 10th, 2024

In a world dominated by data, Datametrex AI emerges as a visionary force, navigating the realms of business intelligence (BI), artificial intelligence (AI), and analytics with unprecedented precision. This article explores the positive industry outlook, intertwining it with Datametrex AI’s strategic trajectory and its ‘FLASH’ milestones that illuminate the company’s journey in the ever-evolving intelligence landscape.

Introduction:

As the sun rises on the landscape of business intelligence and analytics, Datametrex AI stands at the forefront, casting a bright light on the industry’s optimistic trajectory. In a world where BI, AI, and analytics converge, Datametrex AI’s journey is not just noteworthy; it’s illuminating. Let’s delve into the core of this intelligence symphony and discover how Datametrex AI is orchestrating the future.

Industry Outlook and Datametrex AI’s Trajectory:

The article reflects on the buoyant trends within the BI and analytics realm, showcasing how Datametrex AI strategically positions itself in this trajectory. It’s not just about keeping pace; it’s about leading the way into a future where data is not just analyzed but truly understood.

Voices of Authority:

Industry leaders echo Datametrex AI’s strategic brilliance. Their quotes resonate with the company’s direction, underlining not just its significance but its pivotal role in shaping the industry narrative. Datametrex AI doesn’t follow; it guides.

Datametrex AI’s FLASH Highlights:

Unveiling the ‘FLASH’ milestones, this section encapsulates Datametrex AI’s pivotal achievements such as bringing AI & GPT to the masses by officially launching its AI & GPT software, AnalyticsGPT.

AnalyticsGPT scans vast data streams from social media, news, blogs, forums, messengers, and more, making predictive analytics easily accessible. This software is designed to empower businesses with the ability to harness the power of AI for data analysis, research and discovery. The underlying AnalyticsGPT technology was developed in conjunction with and used by the U.S. and Canadian Military for defense initiatives and is characterized by its robustness, reliability, and precision. Enterprises now have access to the new AnalyticsGPT platform, allowing them to leverage this intuitive, user-friendly interface for their own business needs.

Real-world Relevance:

Translating complex contributions into relatable impacts, this section paints a vivid picture of Datametrex AI’s real-world relevance. Analogies and examples become the canvas, where investors can see how Datametrex AI’s innovations translate into tangible benefits.

Looking Ahead with Datametrex AI:

Casting a glance into the future, this section intertwines Datametrex AI’s forward-looking goals with the industry’s optimistic forecast. Datametrex AI isn’t just adapting; it’s pioneering the next chapter in intelligent solutions, inviting investors to be a part of this transformative journey.

Conclusion:

In conclusion, Datametrex AI isn’t just a participant; it’s a luminary in the expansive landscape of BI, AI, and analytics. This article serves as an invitation for investors to embark on a deeper exploration, showcasing Datametrex AI’s promising position in an industry marked by growth, innovation, and the relentless pursuit of understanding data like never before.

YOUR NEXT STEPS

Visit $DM HUB On AGORACOM: https://agoracom.com/ir/DatametrexAI

Visit $DM 5 Minute Research Profile On AGORACOM: https://agoracom.com/ir/DatametrexAI/profile

Visit $DM Official Verified Discussion Forum On AGORACOM: https://agoracom.com/ir/DatametrexAI/forums/discussion

Watch $DM Videos On AGORACOM YouTube Channel:
https://www.youtube.com/@AGORACOMIR/playlists

DISCLAIMER AND DISCLOSURE

This record is published on behalf of the featured company or companies mentioned (Collectively “Clients”), which are paid clients of Agora Internet Relations Corp or AGORACOM Investor Relations Corp. (Collectively “AGORACOM”)

AGORACOM.com is a platform. AGORACOM is an online marketing agency that is compensated by public companies to provide online marketing, branding and awareness through Advertising in the form of content on AGORACOM.com, its related websites (smallcapepicenter.com; smallcappodcast.com; smallcapagora.com) and all of their social media sites (Collectively “AGORACOM Network”) . As such please assume any of the companies mentioned above have paid for the creation, publication and dissemination of this article / post.

You understand that AGORACOM receives either monetary or securities compensation for our services, including creating, publishing and distributing content on behalf of Clients, which includes but is not limited to articles, press releases, videos, interview transcripts, industry bulletins, reports, GIFs, JPEGs, (Collectively “Records”) and other records by or on behalf of clients. Although AGORACOM compensation is not tied to the sale or appreciation of any securities, we stand to benefit from any volume or stock appreciation of our Clients. In exchange for publishing services rendered by AGORACOM on behalf of Clients, AGORACOM receives annual cash and/or securities compensation of typically up to $125,000.

Facts relied upon by AGORACOM are generally provided by clients or gathered by AGORACOM from other public sources including press releases, SEDAR and/or EDGAR filings, website, powerpoint presentations. These facts may be in error and if so, Records created by AGORACOM may be materially different. In our video interviews or video content, opinions are those of our guests or interviewees and do not necessarily reflect the opinion of AGORACOM.

From time to time, reference may be made in our marketing materials to prior Records we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

NO INVESTMENT ADVICE

This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell products or securities.

You understand and agree that no content in this record or published by AGORACOM constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person and that no such content is tailored to any specific person’s needs. We will never advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

Neither the writer of this record nor AGORACOM is an investment advisor. Both are neither licensed to provide nor are making any buy or sell recommendations. For more information about this or any other company, please review their public documents to conduct your own due diligence.

If you have any questions, please direct them to [email protected]

For our full website disclaimer, please visit https://agoracom.com/terms-and-conditions